466 related articles for article (PubMed ID: 32271382)
1. Clinical, Biochemical, and Radiological Profile of Normocalcemic Primary Hyperparathyroidism.
Palermo A; Naciu AM; Tabacco G; Falcone S; Santonati A; Maggi D; D'Onofrio L; Briganti SI; Castellitto D; Casini A; Pedone C; Lelli D; Fabbri A; Bilezikian JP; Napoli N; Pozzilli P; Manfrini S; Cesareo R
J Clin Endocrinol Metab; 2020 Jul; 105(7):. PubMed ID: 32271382
[TBL] [Abstract][Full Text] [Related]
2. Bone status in primary hyperparathyroidism assessed by regional bone mineral density from the whole body scan and QUS imaging at calcaneus.
Chappard C; Roux C; Laugier P; Paillard M; Houillier P
Joint Bone Spine; 2006 Jan; 73(1):86-94. PubMed ID: 15893950
[TBL] [Abstract][Full Text] [Related]
3. The threshold of bone mineral density for vertebral fractures in female patients with primary hyperparathyroidism.
Kaji H; Yamauchi M; Chihara K; Sugimoto T
Eur J Endocrinol; 2005 Sep; 153(3):373-8. PubMed ID: 16131599
[TBL] [Abstract][Full Text] [Related]
4. DXA-based bone strain index in normocalcemic primary hyperparathyroidism.
Tabacco G; Naciu AM; Messina C; Sanson G; Rinaudo L; Cesareo R; Falcone S; Napoli N; Ulivieri FM; Palermo A
Osteoporos Int; 2023 May; 34(5):999-1003. PubMed ID: 36640186
[TBL] [Abstract][Full Text] [Related]
5. Bone Quality as Measured by Trabecular Bone Score in Normocalcemic Primary Hyperparathyroidism.
Naciu AM; Tabacco G; Falcone S; Incognito GG; Chiodini I; Maggi D; Pedone C; Lelli D; Bilezikian JP; Napoli N; Manfrini S; Cesareo R; Palermo A
Endocr Pract; 2021 Oct; 27(10):992-997. PubMed ID: 33962077
[TBL] [Abstract][Full Text] [Related]
6. Vitamin D in Primary Hyperparathyroidism: Effects on Clinical, Biochemical, and Densitometric Presentation.
Walker MD; Cong E; Lee JA; Kepley A; Zhang C; McMahon DJ; Silverberg SJ
J Clin Endocrinol Metab; 2015 Sep; 100(9):3443-51. PubMed ID: 26079779
[TBL] [Abstract][Full Text] [Related]
7. DXA-Based Bone Strain Index: A New Tool to Evaluate Bone Quality in Primary Hyperparathyroidism.
Tabacco G; Naciu AM; Messina C; Sanson G; Rinaudo L; Cesareo R; Falcone S; Manfrini S; Napoli N; Bilezikian JP; Ulivieri FM; Palermo A
J Clin Endocrinol Metab; 2021 Jul; 106(8):2304-2312. PubMed ID: 33963754
[TBL] [Abstract][Full Text] [Related]
8. Individual site-specific bone mineral density gain in normocalcemic primary hyperparathyroidism.
Koumakis E; Souberbielle JC; Payet J; Sarfati E; Borderie D; Kahan A; Cormier C
Osteoporos Int; 2014 Jul; 25(7):1963-8. PubMed ID: 24676846
[TBL] [Abstract][Full Text] [Related]
9. Decreased serum sclerostin levels in patients with primary hyperparathyroidism: a cross-sectional and a longitudinal study.
Ardawi MS; Al-Sibiany AM; Bakhsh TM; Rouzi AA; Qari MH
Osteoporos Int; 2012 Jun; 23(6):1789-97. PubMed ID: 22041864
[TBL] [Abstract][Full Text] [Related]
10. Skeletal effects of vitamin D deficiency among patients with primary hyperparathyroidism.
Lee JH; Kim JH; Hong AR; Kim SW; Shin CS
Osteoporos Int; 2017 May; 28(5):1667-1674. PubMed ID: 28175978
[TBL] [Abstract][Full Text] [Related]
11. Parathyroid hormone response to severe vitamin D deficiency is associated with femoral neck bone mineral density: an observational study of 405 women with hip-fracture.
Di Monaco M; Castiglioni C; Tappero R
Hormones (Athens); 2016 Oct; 15(4):527-533. PubMed ID: 28222407
[TBL] [Abstract][Full Text] [Related]
12. Vitamin D status, seasonal variations, parathyroid adenoma weight and bone mineral density in primary hyperparathyroidism.
Moosgaard B; Vestergaard P; Heickendorff L; Melsen F; Christiansen P; Mosekilde L
Clin Endocrinol (Oxf); 2005 Nov; 63(5):506-13. PubMed ID: 16268801
[TBL] [Abstract][Full Text] [Related]
13. Bone mineral density changes after parathyroidectomy are dependent on biochemical profile.
Lee D; Walker MD; Chen HY; Chabot JA; Lee JA; Kuo JH
Surgery; 2019 Jan; 165(1):107-113. PubMed ID: 30327189
[TBL] [Abstract][Full Text] [Related]
14. Bone Material Strength Index as Measured by Impact Microindentation is Low in Patients with Primary Hyperparathyroidism.
Schoeb M; Winter EM; Sleddering MA; Lips MA; Schepers A; Snel M; Appelman-Dijkstra NM
J Clin Endocrinol Metab; 2021 Jun; 106(7):e2527-e2534. PubMed ID: 33780545
[TBL] [Abstract][Full Text] [Related]
15. Bone mineral density evolution after successful parathyroidectomy in patients with normocalcemic primary hyperparathyroidism.
Koumakis E; Souberbielle JC; Sarfati E; Meunier M; Maury E; Gallimard E; Borderie D; Kahan A; Cormier C
J Clin Endocrinol Metab; 2013 Aug; 98(8):3213-20. PubMed ID: 23783096
[TBL] [Abstract][Full Text] [Related]
16. Normocalcemic Primary Hyperparathyroidism: A Comparison with the Hypercalcemic Form in a Tertiary Referral Population.
Pierreux J; Bravenboer B
Horm Metab Res; 2018 Nov; 50(11):797-802. PubMed ID: 30396209
[TBL] [Abstract][Full Text] [Related]
17. Calciotropic Hormones and the Prevalence of Vertebral Fractures in Chinese Postmenopausal Women with Vitamin D Insufficiency: Peking Vertebral Fracture Study.
Jiajue R; Jiang Y; Qi X; Wang Q; Wang W; Pei Y; Wang X; Huang W; Zheng X; Ning Z; Wang O; Li M; Xing X; Yu W; Xu L; Xia W
Calcif Tissue Int; 2019 Jun; 104(6):622-630. PubMed ID: 30737534
[TBL] [Abstract][Full Text] [Related]
18. Normocalcemic primary hyperparathyroidism: further characterization of a new clinical phenotype.
Lowe H; McMahon DJ; Rubin MR; Bilezikian JP; Silverberg SJ
J Clin Endocrinol Metab; 2007 Aug; 92(8):3001-5. PubMed ID: 17536001
[TBL] [Abstract][Full Text] [Related]
19. Clinical Characteristics of Primary Hyperparathyroidism: 15-Year Experience of 457 Patients in a Single Center in China.
Lin X; Fan Y; Zhang Z; Yue H
Front Endocrinol (Lausanne); 2021; 12():602221. PubMed ID: 33716964
[TBL] [Abstract][Full Text] [Related]
20. Phalangeal quantitative ultrasound technology and dual energy X-ray densitometry in patients with primary hyperparathyroidism: influence of sex and menopausal status.
Camozzi V; Lumachi F; Mantero F; Piccolo M; Luisetto G
Osteoporos Int; 2003 Jul; 14(7):602-8. PubMed ID: 12730752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
